Claire Flaujac
Versailles, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Room-Temperature Stability of Argatroban, Danaparoid, and Fondaparinux in Plasma: A Multicenter Study.
Journal: Thrombosis and haemostasis
Published: July 10, 2026
Laboratory Monitoring of UFH in Different Settings (DEXHEP Study): Association between Anti-Xa Levels, Platelet Factor 4 (PF4) Plasma Levels and Dextran Sulfate.
Journal: Thrombosis and haemostasis
Published: November 18, 2025
Usefulness and Limits of DOAC Removal Agents Based on Activated Charcoal in Thrombophilia Testing: Literature Review and Expert Proposals.
Journal: Thrombosis and haemostasis
Published: September 29, 2025
Stability of hemostatic parameters in whole blood, fresh plasma, and frozen plasma: literature review and recommendations from the French Society of Thrombosis and Hemostasis (SFTH)
Journal: Annales de biologie clinique
Published: August 06, 2025
Analytical Performance of an Automated Method for Measuring von Willebrand Factor Activity in Clinical Samples on the New Analyser sthemO 301.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: May 12, 2025
Overview of practices among French clinical pathologists specialized in haemostasis
Journal: Annales de biologie clinique
Published: March 27, 2025
Drug-Specific Calibration: A Solution to Reagent Variability in Extended Half-Life Factor IX Activity Measurements.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: March 19, 2025
Light transmission aggregometry for platelet function testing: position paper on current recommendations and French proposals for accreditation.
Journal: Platelets
Published: November 18, 2024
Stability of Hemostasis Parameters in Whole Blood, Plasma, and Frozen Plasma: Literature Review and Recommendations of the SFTH (French Society of Thrombosis and Haemostasis).
Journal: Seminars in thrombosis and hemostasis
Published: August 30, 2024
Acquired hemophilia A and emicizumab for the treatment of bleeding: two case report and a literature review
Journal: Annales de biologie clinique
Published: August 16, 2024
Neutralizing protease Nexin-1 in hemophilia patients on emicizumab improves thrombin generation.
Journal: Thrombosis research
Published: June 27, 2024
Last Updated: 09/26/2026